Upon completion of this enduring material module, participants should be better able to:
- Describe the biochemical and pathophysiologic characteristics of dominantly inherited monogenic diabetes and its various forms.
- Explain the impact that a correct diagnosis of diabetes can have on treatment and management.
- Explain how specific diabetes strategies stemming from genetics can be used to optimize care and quality of life.
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Nebraska Medicine. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
The University of Nebraska Medical Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
1.0 Contact Hour Awarded
Nebraska Medicine is approved as a provider of nursing continuing professional development by the Midwest Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Dietitians and Licensed Medical Nutrition Therapists
This activity has been approved for 1.00 Levels 1, 2, and 3 continuing professional education units (CPEUs) by the Commission on Dietetic Registration, Academy of Nutrition and Dietetics.
Disclosures
The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles.
Faculty
The following faculty member has disclosed the following relationships:
- Louis Philipson, MD, PhD
Advisory Committee Member: Nevro
Contracted Researcher: Dompe, Novo Nordisk, Protect Bio
Planning Committee
The following planning committee member has disclosed the following relationships:
- Jon Knezevich, PharmD, BCPS
Speaker: Zealand Pharma
The following planning committee members have nothing to disclose:
- Shelly Kelley, BSN, RN, CDCES
- Anne Knape, MSN, APRN-NP
- Melissa Lockard, BSN, RN, CDCES
- Brenda Ram, CMP, CHCP
- Jacqueline Siebels, BSN, RN, NPD-BC
- Ellie Stull, MSN, RN
- Bailey Wrenn, MA
Release Date: Feb. 22, 2023
Expiration Date: Feb. 22, 2024